Vesper Medical Revenue and Competitors
Estimated Revenue & Valuation
- Vesper Medical's estimated annual revenue is currently $5.8M per year.
- Vesper Medical's estimated revenue per employee is $721,625
Employee Data
- Vesper Medical has 8 Employees.
- Vesper Medical grew their employee count by -58% last year.
Vesper Medical's People
Name | Title | Email/Phone |
---|---|---|
1 | Controller & Treasurer | Reveal Email/Phone |
2 | VP Regulatory Affairs/Quality Assurance/Compliance Officer | Reveal Email/Phone |
3 | Associate Director, Clinical Affairs | Reveal Email/Phone |
4 | Senior Product Development Engineer | Reveal Email/Phone |
5 | Principal Quality Engineer | Reveal Email/Phone |
6 | Document Control Coordinator | Reveal Email/Phone |
7 | Clinical Research Associate | Reveal Email/Phone |
Vesper Medical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $73.5M | 302 | 26% | N/A | N/A |
#2 | $7M | 23 | 0% | N/A | N/A |
#3 | $37.9M | 151 | 13% | N/A | N/A |
#4 | $2.1M | 17 | -78% | $64.3M | N/A |
#5 | $9.3M | 35 | 17% | N/A | N/A |
#6 | $56.2M | 121 | -18% | N/A | N/A |
#7 | $38.9M | 137 | 10% | N/A | N/A |
#8 | $22.1M | 85 | 18% | N/A | N/A |
#9 | $22.1M | 88 | 9% | N/A | N/A |
#10 | $33.4M | 133 | 10% | N/A | N/A |
What Is Vesper Medical?
Vesper Medical is a privately held company shaping the future of treating deep venous disease through the creation of the Vesper DUO Venous Stent System®, a next-generation, modular, and uniquely engineered venous stent portfolio that addresses the multiple anatomical challenges presented by the iliac and femoral veins and provides the ability to customize therapy to a broad range of patient needs.
keywords:N/AN/A
Total Funding
8
Number of Employees
$5.8M
Revenue (est)
-58%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.8M | 8 | N/A | N/A |
#2 | $0.6M | 8 | -47% | N/A |
#3 | $0.6M | 8 | 0% | N/A |
#4 | $0.6M | 8 | N/A | N/A |
#5 | $2.4M | 9 | 0% | N/A |